The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBX.L Regulatory News (CBX)

  • There is currently no data for CBX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of Casino Licences and Issue of Equity

31 Dec 2009 07:00

RNS Number : 8550E
Cubus Lux plc
31 December 2009
 



Cubus Lux plc

("Cubus Lux" or the "Company")

Extension of Casino Licences and Issue of Equity 

Cubus Lux, the Croatia-focused leisure resort operator and developer, announces that it has received confirmation that its uncapped casino operators licence in Croatia, which was due to expire on 31st December 2009, has been extended by the Croatian Government for a further five years (the maximum period of extension available to the Croatian Government to grant). The licence is held in the name of the Company’s Croatian subsidiary company, Cubus Lux doo, and its extension will enable the Group to continue its investment programme into further casinos in Croatia. This extension provides additional potential expansion opportunities, as the new Croatian Gaming Law for casino operators, effective as of January 1st 2010, permits for the first time on-line gaming to be provided by licensees.

 

The Company announces further that it has conditionally allotted 325,000 ordinary shares of 10p each in the capital of the Company ("Shares") at a price of 17.5p each, raising approximately £57,000.

Application has been made for admission of these Shares to trading on AIM ("Admission"), and this is expected to become effective on 7 January 2010. Completion of the share issue (and the issue of the Shares) is conditional on amongst other things Admission having occurred by 7 January 2010.

The Shares will when issued rank pari passu with the existing ordinary shares in issue. The proceeds of the share issue will be used for the continuation of the Molatska residential/commercial project and to provide the Company with additional working capital.

Of the Shares, 75,000 are to be issued to Dodge Private Equity Limited, a company of which Gerhard Huber (the Chairman of Cubus Lux) owns the entire issued share capital.

Following the issue of the Shares, Mr Huber's interests in ordinary shares of 10p each in the Company will be as follows:

Number of ordinary shares

Percentage of ordinary share capital in issue following the issue of the Shares

Options

3,205,862

16.6%

200,000

Following the issue of the Shares, and in conformity with the Financial Services Authority's Disclosure and Transparency Rules, Cubus Lux gives notice that its voting capital consists of:

Ordinary Shares

Nominal Value

Share Capital

Ordinary Shares held in Treasury

19,261,122

10p

£1,926,112.20

-

As Cubus Lux does not hold any ordinary shares in Treasury, its total number of voting rights equals its capital.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Cubus Lux under the FSA's Disclosure and Transparency Rules.

 

For further information about the Company please see www.cubuslux.com or contact: 

Steve McCann

Cubus Lux plc

+44 (0)7787 183 184

Jo Turner/Luke Cairns/Lindsay Mair 

Astaire Securities plc 

+44 (0) 20 7448 4400

Claire Louise Noyce/Stephen Austin, 

Broker Hybridan LLP

+44 (0)20 7947 4350

Pam Spooner

City Road Communications

+44 (0) 20 7248 8010

+44 (0)7858 477 747

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEURRNRKARUOAA
Date   Source Headline
28th Mar 20224:35 pmRNSPrice Monitoring Extension
28th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSDirectorate change
14th Mar 20224:41 pmRNSSecond Price Monitoring Extn
14th Mar 20224:36 pmRNSPrice Monitoring Extension
14th Mar 20222:05 pmRNSSecond Price Monitoring Extn
14th Mar 20222:00 pmRNSPrice Monitoring Extension
14th Mar 20227:00 amRNSLaunch of outdoor marketing campaign
8th Mar 202211:03 amRNSShare purchase by CEO
7th Mar 202211:05 amRNSSecond Price Monitoring Extn
7th Mar 202211:00 amRNSPrice Monitoring Extension
4th Mar 20224:41 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
2nd Mar 20227:00 amRNSExercise of Warrants
1st Mar 20227:00 amRNSLaunch of Rejuvenating Cannabinoid Face Serum
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20222:06 pmRNSSecond Price Monitoring Extn
23rd Feb 20222:01 pmRNSPrice Monitoring Extension
21st Feb 202211:05 amRNSSecond Price Monitoring Extn
21st Feb 202211:00 amRNSPrice Monitoring Extension
21st Feb 20229:05 amRNSSecond Price Monitoring Extn
21st Feb 20229:00 amRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSStrategy and trading update
2nd Feb 20227:00 amRNSWhite paper on cannabinoids and skin aging
7th Jan 20221:00 pmRNSResults of Annual General Meeting
15th Dec 20217:00 amRNSAnnual General Meeting update
8th Dec 20217:00 amRNSGrant of Options to CEO
6th Dec 20211:57 pmRNSPosting of Annual Report and Notice of AGM
6th Dec 20217:00 amRNSAppointment of new CEO
3rd Dec 20217:00 amRNSAnnual results
1st Dec 20217:00 amRNSLaunch of inaugural products & ecommerce platform
11th Nov 20217:00 amRNSAdvertising and PR agencies appointed
8th Nov 20212:05 pmRNSSecond Price Monitoring Extn
8th Nov 20212:00 pmRNSPrice Monitoring Extension
8th Nov 202111:05 amRNSSecond Price Monitoring Extn
8th Nov 202111:00 amRNSPrice Monitoring Extension
1st Nov 20217:00 amRNSGrant of Share Options and update on warrants
4th Oct 20219:06 amRNSSecond Price Monitoring Extn
4th Oct 20219:00 amRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSDirector dealings & TR1 notification
16th Aug 20217:00 amRNSSupply agreement signed with Chanelle McCoy Health
2nd Aug 20217:00 amRNSShare disposal by significant shareholder
28th Jul 20212:06 pmRNSSecond Price Monitoring Extn
28th Jul 20212:00 pmRNSPrice Monitoring Extension
10th Jun 20217:00 amRNSSupply agreement signed with Willow Biosciences
25th May 20217:00 amRNSCellular Goods Interim Results
6th May 20217:00 amRNSGrant of Warrants and Extension of Exercise Period
20th Apr 20212:00 pmRNSPrice Monitoring Extension
12th Apr 20217:00 amRNSCellular Goods boosts team with five appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.